NP_032304.2
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
Molecular Weight
29,181 Da
NCBI Official Full Name
15-hydroxyprostaglandin dehydrogenase
NCBI Official Synonym Full Names
hydroxyprostaglandin dehydrogenase 15 (NAD)
NCBI Protein Information
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
UniProt Protein Name
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
UniProt Synonym Protein Names
Prostaglandin dehydrogenase 1
UniProt Synonym Gene Names
UniProt Comments for Hpgd
Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4 ().
Research Articles on Hpgd
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Pathways associated with Hpgd recombinant protein
Diseases associated with Hpgd recombinant protein
Disease Name |
Pubmed Publications |
Neoplasms Antibodies |
>13 publications with Hpgd and Neoplasms |
Osteoarthropathy, Primary Hypertrophic Antibodies |
>8 publications with Hpgd and Osteoarthropathy, Primary Hypertrophic |
Inflammation Antibodies |
>5 publications with Hpgd and Inflammation |
Colorectal Neoplasms Antibodies |
>4 publications with Hpgd and Colorectal Neoplasms |
Skin Diseases Antibodies |
>3 publications with Hpgd and Skin Diseases |
Carcinoma, Squamous Cell Antibodies |
>2 publications with Hpgd and Carcinoma, Squamous Cell |
Fibrosis Antibodies |
>2 publications with Hpgd and Fibrosis |
Adenocarcinoma Antibodies |
>2 publications with Hpgd and Adenocarcinoma |
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1 Antibodies |
>2 publications with Hpgd and HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1 |
Prostatic Neoplasms Antibodies |
>2 publications with Hpgd and Prostatic Neoplasms |
Organs/Tissues associated with Hpgd recombinant protein
|